| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3688813
[patent_doc_number] => 05691320
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-25
[patent_title] => 'Acylated pyrimidine nucleosides for treatment of systemic inflammation and inflammatory hepatitis'
[patent_app_type] => 1
[patent_app_number] => 8/465454
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15110
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/691/05691320.pdf
[firstpage_image] =>[orig_patent_app_number] => 465454
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/465454 | Acylated pyrimidine nucleosides for treatment of systemic inflammation and inflammatory hepatitis | Jun 4, 1995 | Issued |
Array
(
[id] => 1596103
[patent_doc_number] => 06384194
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-07
[patent_title] => 'Expression and purification of human interleukin-3 and muteins thereof'
[patent_app_type] => B1
[patent_app_number] => 08/461287
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 40
[patent_no_of_words] => 20151
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/384/06384194.pdf
[firstpage_image] =>[orig_patent_app_number] => 08461287
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/461287 | Expression and purification of human interleukin-3 and muteins thereof | Jun 4, 1995 | Issued |
Array
(
[id] => 4082117
[patent_doc_number] => 06054441
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-25
[patent_title] => 'Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis'
[patent_app_type] => 1
[patent_app_number] => 8/463790
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 69
[patent_no_of_words] => 36502
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/054/06054441.pdf
[firstpage_image] =>[orig_patent_app_number] => 463790
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/463790 | Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis | Jun 4, 1995 | Issued |
Array
(
[id] => 3936907
[patent_doc_number] => 05871960
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-16
[patent_title] => 'Nucleic acids encoding CR5 polypeptide, vector and transformed cell thereof, and expression thereof'
[patent_app_type] => 1
[patent_app_number] => 8/463081
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 32239
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/871/05871960.pdf
[firstpage_image] =>[orig_patent_app_number] => 463081
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/463081 | Nucleic acids encoding CR5 polypeptide, vector and transformed cell thereof, and expression thereof | Jun 4, 1995 | Issued |
Array
(
[id] => 4004408
[patent_doc_number] => 06004945
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-21
[patent_title] => 'Use of adenosine compounds to relieve pain'
[patent_app_type] => 1
[patent_app_number] => 8/458572
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 10426
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/004/06004945.pdf
[firstpage_image] =>[orig_patent_app_number] => 458572
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/458572 | Use of adenosine compounds to relieve pain | Jun 1, 1995 | Issued |
Array
(
[id] => 3511763
[patent_doc_number] => 05587472
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-24
[patent_title] => 'Coumarin-labeled nucleoside 5\'-triphosphates'
[patent_app_type] => 1
[patent_app_number] => 8/460027
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4940
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/587/05587472.pdf
[firstpage_image] =>[orig_patent_app_number] => 460027
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/460027 | Coumarin-labeled nucleoside 5'-triphosphates | Jun 1, 1995 | Issued |
Array
(
[id] => 3683725
[patent_doc_number] => 05643607
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-01
[patent_title] => 'Prolonged release microcapsules'
[patent_app_type] => 1
[patent_app_number] => 8/458679
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4875
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/643/05643607.pdf
[firstpage_image] =>[orig_patent_app_number] => 458679
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/458679 | Prolonged release microcapsules | Jun 1, 1995 | Issued |
Array
(
[id] => 3841817
[patent_doc_number] => 05744597
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-28
[patent_title] => 'Stereoselective anion glycosylation process for preparing 2\'-deoxy-2\',2\'-difluoronucleosides and 2\'-deoxy-2\'-fluoronucleosides'
[patent_app_type] => 1
[patent_app_number] => 8/459573
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9221
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 264
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/744/05744597.pdf
[firstpage_image] =>[orig_patent_app_number] => 459573
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/459573 | Stereoselective anion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides | Jun 1, 1995 | Issued |
Array
(
[id] => 3832979
[patent_doc_number] => 05712255
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-27
[patent_title] => 'Treatment of herpes infections with polysubstituted benzimidazoles'
[patent_app_type] => 1
[patent_app_number] => 8/457391
[patent_app_country] => US
[patent_app_date] => 1995-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 48442
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 653
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/712/05712255.pdf
[firstpage_image] =>[orig_patent_app_number] => 457391
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/457391 | Treatment of herpes infections with polysubstituted benzimidazoles | May 31, 1995 | Issued |
| 08/446674 | MULTIPLE ADMINISTRATIONS OF ANTI-TNF ANTIBODY | May 29, 1995 | Abandoned |
Array
(
[id] => 3871664
[patent_doc_number] => 05837858
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-17
[patent_title] => 'Method for polymer synthesis using arrays'
[patent_app_type] => 1
[patent_app_number] => 8/452967
[patent_app_country] => US
[patent_app_date] => 1995-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9217
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/837/05837858.pdf
[firstpage_image] =>[orig_patent_app_number] => 452967
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/452967 | Method for polymer synthesis using arrays | May 29, 1995 | Issued |
Array
(
[id] => 3772281
[patent_doc_number] => 05773603
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-30
[patent_title] => 'Method for treating allergic diseases with adenosine derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/443876
[patent_app_country] => US
[patent_app_date] => 1995-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8773
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 236
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/773/05773603.pdf
[firstpage_image] =>[orig_patent_app_number] => 443876
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/443876 | Method for treating allergic diseases with adenosine derivatives | May 29, 1995 | Issued |
Array
(
[id] => 3833008
[patent_doc_number] => 05712257
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-27
[patent_title] => 'Topically active compositions of mismatched dsRNAs'
[patent_app_type] => 1
[patent_app_number] => 8/447427
[patent_app_country] => US
[patent_app_date] => 1995-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 6723
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/712/05712257.pdf
[firstpage_image] =>[orig_patent_app_number] => 447427
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/447427 | Topically active compositions of mismatched dsRNAs | May 22, 1995 | Issued |
Array
(
[id] => 3775786
[patent_doc_number] => 05808042
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-15
[patent_title] => 'Detritylation of DMT-oligonucleotides using cationic ion-exchange resin'
[patent_app_type] => 1
[patent_app_number] => 8/447760
[patent_app_country] => US
[patent_app_date] => 1995-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 7
[patent_no_of_words] => 4075
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/808/05808042.pdf
[firstpage_image] =>[orig_patent_app_number] => 447760
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/447760 | Detritylation of DMT-oligonucleotides using cationic ion-exchange resin | May 22, 1995 | Issued |
| 08/447494 | METHODS AND COMPOUNDS FOR THE STEREOSELECTIVE ENRICHMENT OF OLIGONUCLEOTIDE DIASTEREOMERS AND OLIGONUCLEOTIDES THEREBY PRODUCED | May 22, 1995 | Abandoned |
Array
(
[id] => 3636331
[patent_doc_number] => 05631361
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-05-20
[patent_title] => 'Method of synthesizing radioisotopically labeled oligonucleotides by direct solid-phase 5\' phosphitylation'
[patent_app_type] => 1
[patent_app_number] => 8/447092
[patent_app_country] => US
[patent_app_date] => 1995-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3870
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/631/05631361.pdf
[firstpage_image] =>[orig_patent_app_number] => 447092
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/447092 | Method of synthesizing radioisotopically labeled oligonucleotides by direct solid-phase 5' phosphitylation | May 21, 1995 | Issued |
Array
(
[id] => 3840230
[patent_doc_number] => 05847104
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-08
[patent_title] => 'Method of tritium labeling oligonucleotide'
[patent_app_type] => 1
[patent_app_number] => 8/447203
[patent_app_country] => US
[patent_app_date] => 1995-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4553
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/847/05847104.pdf
[firstpage_image] =>[orig_patent_app_number] => 447203
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/447203 | Method of tritium labeling oligonucleotide | May 21, 1995 | Issued |
| 08/446185 | GLYCOMIMETIC COMBINATORIAL LIBRARIES | May 18, 1995 | Abandoned |
Array
(
[id] => 3650412
[patent_doc_number] => 05684148
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-04
[patent_title] => 'Nucleoside thiophosphoramidites'
[patent_app_type] => 1
[patent_app_number] => 8/442705
[patent_app_country] => US
[patent_app_date] => 1995-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16890
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/684/05684148.pdf
[firstpage_image] =>[orig_patent_app_number] => 442705
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/442705 | Nucleoside thiophosphoramidites | May 16, 1995 | Issued |
Array
(
[id] => 3704525
[patent_doc_number] => 05674997
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-07
[patent_title] => 'DNA purification on modified siligates'
[patent_app_type] => 1
[patent_app_number] => 8/438938
[patent_app_country] => US
[patent_app_date] => 1995-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6299
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 241
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/674/05674997.pdf
[firstpage_image] =>[orig_patent_app_number] => 438938
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/438938 | DNA purification on modified siligates | May 9, 1995 | Issued |